Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseases (Q38188453)

30 August 2017

Atrial fibrillation as manifestation and consequence of underlying cardiomyopathies: from common conditions to genetic diseases (English)

1 reference

30 August 2017

1 reference

Adam Mohmand-Borkowski

series ordinal

1

1 reference

PubMed ID

24531802

30 August 2017

W H Wilson Tang

series ordinal

2

1 reference

30 August 2017

1 May 2014

1 reference

30 August 2017

Heart Failure Reviews

1 reference

30 August 2017

19

1 reference

30 August 2017

295-304

1 reference

30 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-014-9424-0

30 August 2017

0 references

cites work

Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Left atrial size in 164 hypertensive patients: an echocardiographic and ambulatory blood pressure study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Stretch-activated currents in ventricular myocytes: amplitude and arrhythmogenic effects increase with hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Changes in anisotropic conduction caused by remodeling cell size and the cellular distribution of gap junctions and Na(+) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Congestive heart failure effects on atrial fibroblast phenotype: differences between freshly-isolated and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Management of atrial fibrillation in patients with structural heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Danon disease as a cause of concentric left ventricular hypertrophy in patients who underwent endomyocardial biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Narrative review: Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Arrhythmias in Fabry cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Isolated left ventricular non-compaction controversies in diagnostic criteria, adverse outcomes and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Recovery from prolonged abnormalities of canine myocardium salvaged from ischemic necrosis by coronary reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Reversible cardiomyopathies--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-014-9424-0

Atrial fibrillation substrate: the "unknown species"-- from lone atrial fibrillation to fibrotic atrial cardiomyopathy

21 January 2018

1 reference

12 December 2020

Natural history of Danon disease

1 reference

12 December 2020

Ventricular dysfunction: tachycardia induced cardiomyopathy

1 reference

12 December 2020

Clinical characteristics, treatment, and outcome of tachycardia induced cardiomyopathy

1 reference

12 December 2020

Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy

1 reference

12 December 2020

Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis

1 reference

12 December 2020

Myocardial Na+,K+-ATPase in tachycardia induced cardiomyopathy

1 reference

12 December 2020

Association of angiotensin converting enzyme gene polymorphism with tachycardia cardiomyopathy

1 reference

12 December 2020

Hypertrophic cardiomyopathy

1 reference

12 December 2020

Left ventricular myocardial blood flow, metabolism, and effects of treatment with enalapril: further insights into the mechanisms of canine experimental pacing-induced heart failure

1 reference

12 December 2020

Intracardiac thrombosis and embolism in patients with cardiac amyloidosis

1 reference

12 December 2020

Intra-Atrial Pressure Increases Rate and Organization of Waves Emanating From the Superior Pulmonary Veins During Atrial Fibrillation

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S10741-014-9424-0

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24531802